Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal International Humanities and Applied Science Journal
Indri Kusuma Wardani
Study Program Management, Economy and Business Faculty, Universitas Mercu Buana Jl. Raya Meruya Selatan, Kembangan, Jakarta 11650
Humanities Decision Sciences, Operations Research & Management Economics, Econometrics & Finance Library & Information Science Social Sciences

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Comparative Analysis Of Stock Prices and Trading Volume of Pharmaceutical Companies Before and After The Covid-19 Pandemic (Case Study Of Companies Listed on The IDX 2018-2023) Indri Kusuma Wardani
International Humanities and Applied Science Journal Vol. 9 No. 1 (2026)
Publisher : Universitas Mercu Buana

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Global financial markets, particularly in Indonesia, were significantly affected by the COVID-19 pandemic, and the pharmaceutical sector attracted heightened investor attention during this period. This study compares stock prices and trading transaction volumes of pharmaceutical companies listed on the Indonesia Stock Exchange before and after the COVID-19 outbreak. Using a comparative quantitative approach with purposive sampling, seven firms were selected from a population of eleven over the 2018–2023 period. Because the data were not normally distributed, hypotheses were tested using the non-parametric Wilcoxon Signed Rank Test. The results indicate statistically significant differences in both stock prices and trading transaction volumes between the pre-pandemic and post-pandemic periods. Stock prices increased in the post-pandemic period, reflecting improved valuation of pharmaceutical firms during the crisis, while trading volume also changed significantly, indicating a shift in market participation and liquidity conditions. These findings suggest that the pandemic carried information content that reshaped investor behavior toward pharmaceutical stocks. This study contributes to understanding sectoral market dynamics during global health crises and provides insights for investors, regulators, and corporate managers regarding valuation and liquidity considerations. Keywords: Stock Price, Trading Transaction Volume, Covid-19, Wilcoxon Signed Rank Test   
Co-Authors